Angiosarcoma Treatment Market size is estimated to reach USD 8 billion by the end of 2035, growing at CAGR of 6% during the forecast period i.e., 2024-2036. In the year 2023, the industry size of angiosarcoma treatment was over 245 million. The elderly population has a greater cancer risk, thus resulting in the demand for angiosarcoma treatment. Over 703 million people over the age of 65 live in the world today, making up 9.1% of all people, according to the Union for International Cancer Control (UICC). By 2050, it is predicted that this percentage would increase to 15.9%. According to UICC, the total cancer-related death rate for those aged 70 and above is expected to be 65,17,865 by 2030. Angiosarcomas Treatment Industry would expand over the forecast period as a result of an increasing incidence and high mortality rate of cancer-related diseases in the senior population.
The increased use of sophisticated cancer therapeutic alternatives and the rising demand for targeted drugs and immunotherapy as disease treatments both contribute to the market's rapid expansion. The development of bioinformatic tools increasing the drug development process as well as the introduction of emerging therapeutic classes, such as monoclonal antibodies and histone deacetylase (HDAC) inhibitors, have a significant impact on the market.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024 – 2036 |
|
CAGR |
~6% |
|
Base Year Market Size |
~USD 245 million |
|
Forecast Year Market Size |
~USD 8 billion |
|
Regional Scope |
|
Treatment (Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy)
Angiosarcoma treatment market from the surgery segment is anticipated to account for the largest revenue share during the forecast period. This is because the need for biopsies to study various types of cancer is increasing. It also helps in proper diagnosis and treatment and plays an important role in various types of cancer services. According to cancer statistics, in 2021, the American Cancer Society performed more than 1 million biopsies in the United States. Due to the prevalence of cancer globally, increased demand for cancer surgery has been reported in recent years. According to a study published in January 2021, indications for cancer surgery will increase by 5 million interventions (52%) from 2018 (90,65,000) to 2040 (1.38 ,21,000). Such increasing demand for cancer surgery is driving the growth in angiosarcoma treatment market share.
End-Users (Hospitals, Homecare, Ambulatory Care Centre)
Based on end user, the ambulatory care center segment is poised to be the fastest growing segment in the angiosarcoma treatment market. This may be due to the characteristics of ambulatory centers that provide patients with chemotherapy regimens in an inpatient setting and supportive care provided in an outpatient setting. There, instead of spending the night in a hospital bed, patients stay in a nearby hotel or in their homes while receiving daily treatment and supportive care in an outpatient care facility. Because of these facilities, most people prefer outpatient care centers to long-term hospital stays. The growing popularity of outpatient centers to treat various cancers is driving the growth of angiosarcoma treatments in the projected time period.
Our in-depth analysis of the global angiosarcoma treatment market includes the following segments:
|
Treatment |
|
|
Location of Instigation |
|
|
End-Users |
|
|
Distribution Channel |
|
North America Market Forecasts
The North America region is predicted to account for 35% share of the global angiosarcoma treatment market by the end of 2035. This is due to the development of medical infrastructure and government policies that favor the research and development of new drugs and treatments. According to the National Cancer Institute, the cancer research budget increased by 99.3 million (1.6%) from 2020 to 2021. Additionally, cases of angiosarcomas as well as lymphedema and syncope are increasing. increased in this area. In the United States, one case of angiosarcoma is diagnosed each year in every million people. About 1 to 2% of all sarcomas are angiosarcomas.
APAC Market Statistics
The angiosarcoma treatment market in Asia Pacific region is expected to grow substantially during the forecast period. The growth of this market can be ascribed on the back of an increasing number of old age population found in this region. Due to weakening body functions and less immunity the old population in the region majorly suffers from cancer as compared to the middle or young adults which is predicted to raise the market growth of the angiosarcoma treatment market in the projected time period.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?